NATIXIS ADVISORS, L.P. - MYRIAD GENETICS INC ownership

MYRIAD GENETICS INC's ticker is MYGN and the CUSIP is 62855J104. A total of 184 filers reported holding MYRIAD GENETICS INC in Q3 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.0%.

Quarter-by-quarter ownership
NATIXIS ADVISORS, L.P. ownership history of MYRIAD GENETICS INC
ValueSharesWeighting
Q3 2023$2,115
-34.1%
131,829
-4.8%
0.01%
-40.0%
Q2 2023$3,211
+27.0%
138,524
+27.2%
0.01%
+11.1%
Q1 2023$2,529
+200.0%
108,879
+87.4%
0.01%
+200.0%
Q4 2022$843
-99.9%
58,106
+10.5%
0.00%
-25.0%
Q3 2022$1,003,000
+211.5%
52,568
+197.1%
0.00%
+300.0%
Q2 2022$322,000
-13.4%
17,695
+19.9%
0.00%0.0%
Q1 2022$372,000
-86.8%
14,757
-86.5%
0.00%
-96.8%
Q2 2017$2,824,000
+55.0%
109,275
+15.1%
0.03%
+55.0%
Q1 2017$1,822,000
+23.2%
94,900
+7.0%
0.02%
+11.1%
Q4 2016$1,479,000
-20.9%
88,698
-2.4%
0.02%
-25.0%
Q3 2016$1,870,000
-27.7%
90,843
+7.4%
0.02%
-33.3%
Q2 2016$2,588,000
+6.7%
84,571
+30.5%
0.04%0.0%
Q1 2016$2,425,000
+115.0%
64,792
+147.9%
0.04%
+100.0%
Q4 2015$1,128,000
+65.6%
26,134
+43.8%
0.02%
+50.0%
Q3 2015$681,000
+24.0%
18,168
+12.4%
0.01%
+33.3%
Q2 2015$549,000
-2.8%
16,166
+1.4%
0.01%
-10.0%
Q1 2015$565,000
+16.7%
15,949
+12.3%
0.01%
+11.1%
Q4 2014$484,000
-10.5%
14,206
+1.3%
0.01%
-18.2%
Q3 2014$541,000
+11.1%
14,026
+12.0%
0.01%
+57.1%
Q2 2014$487,000
-6.3%
12,520
-17.7%
0.01%
-12.5%
Q1 2014$520,000
-58.0%
15,206
-74.2%
0.01%
-60.0%
Q4 2013$1,237,000
+8.9%
58,944
+21.9%
0.02%
-4.8%
Q3 2013$1,136,000
-2.6%
48,338
+11.3%
0.02%
-8.7%
Q2 2013$1,166,00043,4280.02%
Other shareholders
MYRIAD GENETICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Camber Capital Management LP 5,000,000$90,850,0003.94%
Altium Capital Management LP 221,000$4,016,0001.61%
DISCIPLINED GROWTH INVESTORS INC /MN 1,900,787$34,537,0000.93%
Zebra Capital Management LLC 15,352$279,0000.82%
PFM Health Sciences, LP 1,177,250$21,391,0000.82%
EARNEST PARTNERS LLC 6,462,138$117,417,0000.78%
Glenview Capital Management 1,696,791$30,831,0000.77%
AIMZ Investment Advisors, LLC 42,085$765,0000.37%
Phocas Financial Corp. 127,949$2,325,0000.35%
Redhawk Wealth Advisors, Inc. 34,680$630,0000.29%
View complete list of MYRIAD GENETICS INC shareholders